GitLab believes non-GAAP measures are useful in evaluating its operating performance. GitLab uses this supplemental information to evaluate its ongoing operations and for internal planning and forecasting purposes. GitLab believes that non-GAAP financial information, when taken collectively with its GAAP financial information, may be helpful to investors because it provides consistency and comparability with past financial performance. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool, and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. Reconciliations of non-GAAP financial measures to the most directly comparable financial results as determined in accordance with GAAP are included at the end of this press release following the accompanying financial data. We define non-GAAP financial measures as GAAP measures, excluding certain items such as stock-based compensation expense, amortization of acquired intangible assets, foreign exchange (gain) loss, equity method investment loss and impairment, acquisition related expenses, charitable donation of common stock, restructuring charges, a non-recurring income tax adjustment related to bilateral advance pricing agreement ("BAPA") negotiations, non-recurring charges associated with the formation of our GitLab Information Technology (Hubei) Co., LTD Joint Venture in China ("JiHu"), and other expenses that the Company believes are not indicative of its ongoing operations. In addition to these exclusions, effective Q1 FY26 we utilize a fixed long-term projected tax rate in our computation of the non-GAAP income tax provision which reflects the new location of GitLab's intellectual property in the U.S. following the conclusion of our bilateral advance pricing agreements. For FY26 and FY27, we have determined the projected non-GAAP tax rate to be 22%. Shares used for net income per share on a non-GAAP basis include incremental dilutive shares related to restricted stock units, options, and shares issuable under GitLab Inc.'s 2021 Employee Stock Purchase Plan that are anti-dilutive on a GAAP basis. A reconciliation of non-GAAP guidance measures to corresponding GAAP measures is not available on a forward-looking basis without unreasonable effort due to the uncertainty of expenses that may be incurred in the future. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures and not rely on any single financial measure to evaluate our business.
Adjusted Free Cash FlowAdjusted free cash flow is a non-GAAP financial measure that we calculate as net cash provided by operating activities less cash used for purchases of property and equipment, plus any non-recurring income tax payments related to the BAPA or minus any non-recurring income tax refunds related to the BAPA, plus any non-recurring payments related to the formation of JiHu. We believe that adjusted free cash flow is a useful indicator of liquidity that provides information to management and investors about the amount of cash generated from our operations that, after the investments in property and equipment, any non-recurring income tax payments or refunds related to the BAPA, and any non-recurring payments related to the formation of JiHu, can be used for strategic initiatives, including investing in our business, and strengthening our financial position. One limitation of adjusted free cash flow is that it does not reflect our future contractual commitments. Additionally, adjusted free cash flow does not represent the total increase or decrease in our cash balance for a given period.
April 30, 2026 | January 31, 2026 | October 31, 2025 | July 31, 2025 | April 30, 2025 | January 31, 2025 | October 31, 2024 | July 31, 2024 | |
ASSETS | ||||||||
CURRENT ASSETS: | ||||||||
Cash and cash equivalents .............................................................................. | $ 335,395 | $ 229,576 | $ 224,231 | $ 261,371 | $ 255,719 | $ 227,649 | $ 176,632 | $ 438,616 |
Short-term investments..................................................................................... | 1,022,117 | 1,030,327 | 980,077 | 903,806 | 849,113 | 764,728 | 740,340 | 644,488 |
Accounts receivable, net................................................................................... | 200,302 | 304,301 | 221,140 | 197,775 | 201,408 | 264,565 | 197,555 | 165,001 |
Deferred contract acquisition costs, current .................................................. | 39,108 | 42,676 | 36,522 | 35,306 | 35,455 | 38,964 | 34,518 | 33,841 |
Prepaid expenses and other current assets.................................................. | 42,483 | 48,899 | 44,979 | 37,912 | 39,066 | 40,411 | 46,641 | 35,879 |
Total current assets ........................................................................................... | 1,639,405 | 1,655,779 | 1,506,949 | 1,436,170 | 1,380,761 | 1,336,317 | 1,195,686 | 1,317,825 |
Property and equipment, net............................................................................ | 12,777 | 11,815 | 10,193 | 7,642 | 4,856 | 4,013 | 3,563 | 2,899 |
Goodwill............................................................................................................... | 17,798 | 17,379 | 16,919 | 16,634 | 16,029 | 16,139 | 16,131 | 16,017 |
Intangible assets, net......................................................................................... | 7,759 | 9,774 | 11,789 | 13,804 | 15,819 | 17,834 | 19,536 | 21,867 |
Deferred contract acquisition costs, non-current .......................................... | 23,810 | 23,705 | 20,288 | 18,961 | 19,830 | 20,142 | 17,248 | 15,753 |
Other non-current assets.................................................................................. | 3,984 | 4,295 | 4,701 | 4,976 | 4,695 | 4,818 | 3,996 | 5,370 |
TOTAL ASSETS ................................................................................................ | $ 1,705,533 | $ 1,722,747 | $ 1,570,839 | $ 1,498,187 | $ 1,441,990 | $ 1,399,263 | $ 1,256,160 | $ 1,379,731 |
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
CURRENT LIABILITIES: | ||||||||
Accounts payable............................................................................................... | $ 8,847 | $ 9,205 | $ 9,187 | $ 11,395 | $ 11,288 | $ 7,519 | $ 2,224 | $ 3,219 |
Accrued expenses and other current liabilities.............................................. | 72,680 | 58,185 | 58,406 | 52,339 | 66,308 | 54,680 | 68,137 | 287,811 |
Accrued compensation and benefits............................................................... | 28,538 | 39,657 | 33,402 | 30,164 | 28,119 | 40,233 | 27,274 | 29,117 |
Deferred revenue, current................................................................................. | 532,983 | 545,096 | 464,813 | 459,459 | 450,668 | 442,599 | 383,183 | 362,348 |
Total current liabilities........................................................................................ | 643,048 | 652,143 | 565,808 | 553,357 | 556,383 | 545,031 | 480,818 | 682,495 |
Deferred revenue, non-current......................................................................... | 23,991 | 26,994 | 28,977 | 25,749 | 25,981 | 26,369 | 14,138 | 14,732 |
Other non-current liabilities............................................................................... | 7,108 | 7,362 | 8,057 | 7,499 | 7,029 | 6,557 | 3,776 | 6,678 |
TOTAL LIABILITIES .......................................................................................... | 674,147 | 686,499 | 602,842 | 586,605 | 589,393 | 577,957 | 498,732 | 703,905 |
STOCKHOLDERS' EQUITY: | ||||||||
Additional paid-in capital................................................................................... | 2,209,247 | 2,207,361 | 2,141,732 | 2,080,759 | 2,013,228 | 1,952,031 | 1,891,653 | 1,833,786 |
Accumulated deficit............................................................................................ | (1,228,542) | (1,223,570) | (1,220,973) | (1,212,697) | (1,203,489) | (1,167,614) | (1,174,506) | (1,203,609) |
Accumulated other comprehensive income (loss)........................................ | 4,499 | 6,877 | 1,956 | (1,511) | (1,459) | (8,508) | (5,098) | 623 |
Total GitLab stockholders' equity .................................................................... | 985,204 | 990,668 | 922,715 | 866,551 | 808,280 | 775,909 | 712,049 | 630,800 |
Noncontrolling interests..................................................................................... | 46,182 | 45,580 | 45,282 | 45,031 | 44,317 | 45,397 | 45,379 | 45,026 |
TOTAL STOCKHOLDERS' EQUITY .............................................................. | 1,031,386 | 1,036,248 | 967,997 | 911,582 | 852,597 | 821,306 | 757,428 | 675,826 |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY.............................. | $ 1,705,533 | $ 1,722,747 | $ 1,570,839 | $ 1,498,187 | $ 1,441,990 | $ 1,399,263 | $ 1,256,160 | $ 1,379,731 |
Three Months Ended | ||||||||
April 30, 2026 | January 31, 2026 | October 31, 2025 | July 31, 2025 | April 30, 2025 | January 31, 2025 | October 31, 2024 | July 31, 2024 | |
Revenue: | ||||||||
Subscription-self-managed and SaaS....................................... | $ 239,306 | $ 234,277 | $ 223,262 | $ 212,684 | $ 194,481 | $ 185,562 | $ 175,257 | $ 163,181 |
License-self-managed and other................................................ | 24,852 | 26,125 | 21,091 | 23,276 | 20,028 | 25,869 | 20,790 | 19,403 |
Total revenue ....................................................................... | 264,158 | 260,402 | 244,353 | 235,960 | 214,509 | 211,431 | 196,047 | 182,584 |
Cost of revenue: | ||||||||
Subscription-self-managed and SaaS....................................... | 30,591 | 28,297 | 25,184 | 21,753 | 19,268 | 17,277 | 17,170 | 16,630 |
License-self-managed and other................................................ | 6,897 | 6,685 | 7,037 | 6,752 | 5,767 | 5,592 | 4,955 | 4,740 |
Total cost of revenue........................................................ | 37,488 | 34,982 | 32,221 | 28,505 | 25,035 | 22,869 | 22,125 | 21,370 |
Gross profit ................................................................................................... | 226,670 | 225,420 | 212,132 | 207,455 | 189,474 | 188,562 | 173,922 | 161,214 |
Operating expenses: | ||||||||
Sales and marketing ....................................................................... | 119,358 | 112,581 | 104,974 | 109,583 | 107,587 | 98,753 | 95,340 | 97,778 |
Research and development........................................................... | 71,482 | 68,961 | 68,715 | 71,488 | 65,410 | 62,885 | 61,354 | 61,273 |
General and administrative ............................................................ | 51,579 | 49,042 | 50,799 | 44,735 | 51,087 | 46,262 | 45,960 | 43,168 |
Total operating expenses........................................................................... | 242,419 | 230,584 | 224,488 | 225,806 | 224,084 | 207,900 | 202,654 | 202,219 |
Loss from operations................................................................................... | (15,749) | (5,164) | (12,356) | (18,351) | (34,610) | (19,338) | (28,732) | (41,005) |
Interest income............................................................................................. | 11,947 | 11,630 | 11,704 | 11,511 | 10,862 | 10,292 | 12,586 | 12,827 |
Other income (expense), net ..................................................................... | 255 | (6,075) | (6,334) | (911) | (9,971) | 4,017 | 4,799 | 1,260 |
Income (loss) before income taxes........................................................... | (3,547) | 391 | (6,986) | (7,751) | (33,719) | (5,029) | (11,347) | (26,918) |
Provision for (benefit from) income taxes................................................ | 2,032 | 3,904 | 1,811 | 2,245 | 2,539 | (11,344) | (39,152) | (39,155) |
Net income (loss)......................................................................................... | $ (5,579) | $ (3,513) | $ (8,797) | $ (9,996) | $ (36,258) | $ 6,315 | $ 27,805 | $ 12,237 |
Net loss attributable to noncontrolling interest........................................ | (607) | (916) | (521) | (788) | (383) | (577) | (1,298) | (675) |
Net income (loss) attributable to GitLab................................................... | $ (4,972) | $ (2,597) | $ (8,276) | $ (9,208) | $ (35,875) | $ 6,892 | $ 29,103 | $ 12,912 |
Net income (loss) per share attributable to GitLab Class A and Class B common stockholders:............................................................. | ||||||||
Basic .............................................................................................................. | $ (0.03) | $ (0.02) | $ (0.05) | $ (0.06) | $ (0.22) | $ 0.04 | $ 0.18 | $ 0.08 |
Diluted ........................................................................................................... | $ (0.03) | $ (0.02) | $ (0.05) | $ (0.06) | $ (0.22) | $ 0.04 | $ 0.17 | $ 0.08 |
Weighted-average shares used to compute net income (loss) per share attributable to GitLab Class A and Class B common stockholders:............................................................................................ | ||||||||
Basic .............................................................................................................. | 169,948 | 169,231 | 167,407 | 165,953 | 164,491 | 163,055 | 161,317 | 159,677 |
Diluted ........................................................................................................... | 169,948 | 169,231 | 167,407 | 165,953 | 164,491 | 170,094 | 167,436 | 166,346 |
April 30, 2026 | January 31, 2026 | October 31, 2025 | July 31, 2025 | April 30, 2025 | January 31, 2025 | October 31, 2024 | July 31, 2024 | |
Gross profit on GAAP basis | $ 226,670 | $ 225,420 | $ 212,132 | $ 207,455 | $ 189,474 | $ 188,562 | $ 173,922 | $ 161,214 |
Stock-based compensation expense ........................................... | 2,864 | 3,823 | 2,300 | 2,261 | 1,929 | 1,998 | 1,993 | 2,076 |
Amortization of acquired intangibles............................................. | 2,015 | 2,015 | 2,015 | 2,015 | 2,020 | 2,195 | 2,511 | 2,333 |
Restructuring charges..................................................................... | - | 153 | - | - | - | - | - | - |
Gross profit on non-GAAP basis | $ 231,549 | $ 231,411 | $ 216,447 | $ 211,731 | $ 193,423 | $ 192,755 | $ 178,426 | $ 165,623 |
Gross margin on non-GAAP basis .............................................. | 88 % | 89 % | 89 % | 90 % | 90 % | 91 % | 91 % | 91 % |
Sales and marketing on GAAP basis | $ 119,358 | $ 112,581 | $ 104,974 | $ 109,583 | $ 107,587 | $ 98,753 | $ 95,340 | $ 97,778 |
Stock-based compensation expense ........................................... | (17,445) | (19,572) | (17,354) | (19,950) | (22,091) | (18,664) | (17,012) | (19,881) |
Restructuring charges..................................................................... | - | (1,493) | - | - | - | - | (130) | (266) |
Sales and marketing on non-GAAP basis | $ 101,913 | $ 91,516 | $ 87,620 | $ 89,633 | $ 85,496 | $ 80,089 | $ 78,198 | $ 77,631 |
Research and development on GAAP basis | $ 71,482 | $ 68,961 | $ 68,715 | $ 71,488 | $ 65,410 | $ 62,885 | $ 61,354 | $ 61,273 |
Stock-based compensation expense ........................................... | (13,630) | (14,725) | (15,560) | (19,197) | (14,272) | (15,478) | (14,384) | (16,114) |
Restructuring charges..................................................................... | - | - | - | - | - | - | - | (393) |
Research and development on non-GAAP basis | $ 57,852 | $ 54,236 | $ 53,155 | $ 52,291 | $ 51,138 | $ 47,407 | $ 46,970 | $ 44,766 |
General and administrative on GAAP basis | $ 51,579 | $ 49,042 | $ 50,799 | $ 44,735 | $ 51,087 | $ 46,262 | $ 45,960 | $ 43,168 |
Stock-based compensation expense ........................................... | (16,122) | (15,038) | (16,468) | (12,876) | (17,535) | (10,496) | (14,653) | (10,898) |
Restructuring charges..................................................................... | - | - | - | - | - | - | 11 | (112) |
Charitable donation of common stock.......................................... | (821) | (1,597) | (1,970) | (1,787) | (1,739) | (2,957) | (2,957) | (2,957) |
Changes in the fair value of acquisition related contingent consideration .................................................................................... | - | - | - | - | - | - | - | (3,750) |
Acquisition related expenses......................................................... | (310) | (216) | (321) | (157) | (183) | (391) | (140) | (658) |
Other non-recurring charges.......................................................... | (76) | 77 | (48) | 320 | (963) | (4,538) | (872) | 261 |
General and administrative on non-GAAP basis | $ 34,250 | $ 32,268 | $ 31,992 | $ 30,235 | $ 30,667 | $ 27,880 | $ 27,349 | $ 25,054 |
Loss from operations on GAAP basis | $ (15,749) | $ (5,164) | $ (12,356) | $ (18,351) | $ (34,610) | $ (19,338) | $ (28,732) | $ (41,005) |
Stock-based compensation expense ........................................... | 50,061 | 53,158 | 51,682 | 54,284 | 55,827 | 46,636 | 48,042 | 48,969 |
Amortization of acquired intangibles............................................. | 2,015 | 2,015 | 2,015 | 2,015 | 2,020 | 2,195 | 2,511 | 2,333 |
Restructuring charges..................................................................... | - | 1,646 | - | - | - | - | 119 | 771 |
Charitable donation of common stock.......................................... | 821 | 1,597 | 1,970 | 1,787 | 1,739 | 2,957 | 2,957 | 2,957 |
Changes in the fair value of acquisition related contingent consideration .................................................................................... | - | - | - | - | - | - | - | 3,750 |
Acquisition related expenses......................................................... | 310 | 216 | 321 | 157 | 183 | 391 | 140 | 658 |
Other non-recurring charges.......................................................... | 76 | (77) | 48 | (320) | 963 | 4,538 | 872 | (261) |
Income from operations on non-GAAP basis | $ 37,534 | $ 53,391 | $ 43,680 | $ 39,572 | $ 26,122 | $ 37,379 | $ 25,909 | $ 18,172 |
Other income (expense), net on GAAP basis | $ 255 | $ (6,075) | $ (6,334) | $ (911) | $ (9,971) | $ 4,017 | $ 4,799 | $ 1,260 |
Foreign exchange gains (losses), net .......................................... | (536) | 6,032 | 2,362 | 1,117 | 9,954 | (3,860) | (5,074) | (1,267) |
Other non-recurring charges.......................................................... | 182 | 178 | 3,714 | 172 | 170 | 173 | 171 | 172 |
Other income (expense), net on non-GAAP basis | $ (99) | $ 135 | $ (258) | $ 378 | $ 153 | $ 330 | $ (104) | $ 165 |
Net income (loss) attributable to GitLab common stockholders on GAAP basis | $ (4,972) | $ (2,597) | $ (8,276) | $ (9,208) | $ (35,875) | $ 6,892 | $ 29,103 | $ 12,912 |
Stock-based compensation expense ........................................... | 50,061 | 53,158 | 51,682 | 54,284 | 55,827 | 46,636 | 48,042 | 48,969 |
Amortization of acquired intangibles............................................. | 2,015 | 2,015 | 2,015 | 2,015 | 2,020 | 2,195 | 2,511 | 2,333 |
Restructuring charges..................................................................... | - | 1,646 | - | - | - | - | 119 | 771 |
Charitable donation of common stock.......................................... | 821 | 1,597 | 1,970 | 1,787 | 1,739 | 2,957 | 2,957 | 2,957 |
Changes in the fair value of acquisition related contingent consideration .................................................................................... | - | - | - | - | - | - | - | 3,750 |
Acquisition related expenses......................................................... | 310 | 216 | 321 | 157 | 183 | 391 | 140 | 658 |
Foreign exchange gains (losses), net .......................................... | (536) | 6,032 | 2,362 | 1,117 | 9,954 | (3,860) | (5,074) | (1,267) |
Income tax adjustment.................................................................... | (8,966) | (10,428) | (10,318) | (9,077) | (5,631) | (3,222) | (39,696) | (46,472) |
Other non-recurring charges.......................................................... | 258 | 101 | 3,762 | (148) | 1,133 | 4,711 | 1,043 | (89) |
Net income attributable to GitLab common stockholders on non-GAAP basis | $ 38,991 | $ 51,740 | $ 43,518 | $ 40,927 | $ 29,350 | $ 56,700 | $ 39,145 | $ 24,522 |
GAAP net income (loss) per share, basic | $ (0.03) | $ (0.02) | $ (0.05) | $ (0.06) | $ (0.22) | $ 0.04 | $ 0.18 | $ 0.08 |
GAAP net income (loss) per share, diluted | $ (0.03) | $ (0.02) | $ (0.05) | $ (0.06) | $ (0.22) | $ 0.04 | $ 0.17 | $ 0.08 |
Non-GAAP net income per share, basic | $ 0.23 | $ 0.31 | $ 0.26 | $ 0.25 | $ 0.18 | $ 0.35 | $ 0.24 | $ 0.15 |
Non-GAAP net income per share, diluted | $ 0.23 | $ 0.30 | $ 0.25 | $ 0.24 | $ 0.17 | $ 0.33 | $ 0.23 | $ 0.15 |
Shares used in per share calculation - basic on GAAP basis | 169,948 | 169,231 | 167,407 | 165,953 | 164,491 | 163,055 | 161,317 | 159,677 |
Effect of dilutive securities.............................................................. | 1,567 | 2,882 | 4,324 | 4,535 | 5,669 | 7,039 | 6,119 | 6,669 |
Shares used in per share calculation - diluted on non-GAAP basis | 171,515 | 172,113 | 171,731 | 170,488 | 170,160 | 170,094 | 167,436 | 166,346 |
Computation of adjusted free cash flow | ||||||||
GAAP net cash provided by (used in) operating activities | $ 149,197 | $ 45,757 | $ 31,428 | $ 49,369 | $ 106,302 | $ 63,222 | $ (177,028) | $ 11,697 |
Less: Additions to property and equipment | (2,393) | (3,973) | (3,038) | (2,904) | (912) | (1,157) | (1,057) | (851) |
Add: Income tax payment (refunds) related to BAPA | (77) | (28) | (1,146) | (12) | (1,293) | - | 187,735 | - |
Non-GAAP adjusted free cash flow | $ 146,727 | $ 41,756 | $ 27,244 | $ 46,453 | $ 104,097 | $ 62,065 | $ 9,650 | $ 10,846 |
Three Months Ended | ||||||||
April 30, 2026 | January 31, 2026 | October 31, 2025 | July 31, 2025 | April 30, 2025 | January 31, 2025 | October 31, 2024 | July 31, 2024 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||
Net income (loss), including amounts attributable to noncontrolling interest ............................................................................................................ | $ (5,579) | $ (3,513) | $ (8,797) | $ (9,996) | $ (36,258) | $ 6,315 | $ 27,805 | $ 12,237 |
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | ||||||||
Stock-based compensation expense, net of amounts capitalized ..... | 50,061 | 53,158 | 51,682 | 54,284 | 55,827 | 46,636 | 48,042 | 48,969 |
Change in fair value of acquisition related contingent consideration. | - | - | - | - | - | - | - | 3,750 |
Charitable donation of common stock .................................................... | 821 | 1,597 | 1,970 | 1,787 | 1,739 | 2,956 | 2,957 | 2,957 |
Amortization of intangible assets............................................................. | 2,015 | 2,015 | 2,015 | 2,015 | 2,020 | 2,195 | 2,511 | 2,333 |
Depreciation and amortization ................................................................. | 1,295 | 1,096 | 869 | 759 | 556 | 499 | 680 | 744 |
Amortization of deferred contract acquisition costs.............................. | 12,924 | 14,139 | 13,478 | 13,370 | 13,899 | 14,064 | 12,704 | 11,837 |
Net amortization of premiums or discounts on short-term investments................................................................................................. | (324) | (861) | (1,741) | (2,609) | (2,996) | (3,813) | (3,792) | (4,241) |
Unrealized foreign exchange loss (gain), net ........................................ | (1,011) | 5,425 | 2,416 | 1,069 | 9,901 | (4,083) | (5,175) | (988) |
Other non-cash expense (income), net .................................................. | 189 | 367 | 231 | 192 | 208 | 162 | 467 | (111) |
Changes in assets and liabilities: | ||||||||
Accounts receivable................................................................................ | 103,356 | (82,033) | (23,472) | 3,859 | 65,928 | (67,991) | (32,883) | (29,847) |
Prepaid expenses and other current assets ....................................... | 6,387 | (3,832) | (7,036) | 1,219 | 1,527 | 5,927 | (10,847) | 2,982 |
Deferred contract acquisition costs...................................................... | (9,745) | (22,966) | (15,898) | (12,304) | (8,126) | (22,421) | (14,751) | (12,415) |
Other non-current assets ....................................................................... | 228 | 395 | 233 | (198) | 379 | (1,034) | 1,348 | (78) |
Accounts payable.................................................................................... | (353) | 794 | (2,302) | (472) | 3,586 | 5,472 | (1,317) | 14 |
Accrued expenses and other current liabilities................................... | 14,451 | (624) | 6,140 | (14,257) | 9,979 | (12,755) | (219,544) | (41,093) |
Accrued compensation and benefits.................................................... | (10,970) | 5,765 | 3,168 | 2,021 | (13,084) | 13,558 | (1,913) | 6,250 |
Deferred revenue .................................................................................... | (14,288) | 75,781 | 8,011 | 8,284 | 1,205 | 74,240 | 19,665 | 19,286 |
Other non-current liabilities.................................................................... | (260) | (946) | 461 | 346 | 12 | 3,295 | (2,985) | (10,889) |
Net cash provided by (used in) operating activities........... | 149,197 | 45,757 | 31,428 | 49,369 | 106,302 | 63,222 | (177,028) | 11,697 |
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
Purchases of short-term investments ........................................................ | (222,196) | (213,209) | (314,385) | (237,946) | (245,952) | (204,304) | (240,136) | (118,866) |
Proceeds from maturities of short-term investments............................... | 218,824 | 164,139 | 241,641 | 184,280 | 163,606 | 183,520 | 148,763 | 121,412 |
Proceeds from sales of short-term investments....................................... | 9,922 | - | - | - | 1,367 | - | - | - |
Additions to property and equipment ......................................................... | (2,393) | (3,973) | (3,038) | (2,904) | (912) | (1,157) | (1,057) | (851) |
Payments for asset acquisition ................................................................... | - | - | - | - | - | - | (346) | (7,314) |
Other investing activities.............................................................................. | - | - | - | - | - | - | - | 457 |
Net cash provided by (used in) investing activities ........... | 4,157 | (53,043) | (75,782) | (56,570) | (81,891) | (21,941) | (92,776) | (5,162) |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
Proceeds from the issuance of common stock upon exercise of stock options, including early exercises, net of repurchases ........................... | 2,373 | 6,324 | 8,182 | 3,947 | 3,328 | 6,069 | 7,822 | 4,980 |
Issuance of common stock under employee stock purchase plan | - | 5,571 | - | 8,404 | - | 5,624 | - | 7,932 |
Common stock repurchased | (50,048) | - | - | - | - | - | - | - |
Payments for taxes related to net share settlement of equity awards | (160) | (416) | (529) | - | - | - | - | - |
Net cash provided by (used in) financing activities.......... | (47,835) | 11,479 | 7,653 | 12,351 | 3,328 | 11,693 | 2,922 | 12,912 |
Impact of foreign exchange on cash and cash equivalents ................... | 300 | 1,152 | (439) | 502 | 331 | (1,957) | 4,898 | (1,153) |
Net increase (decrease) in cash and cash equivalents .......................... | 105,819 | 5,345 | (37,140) | 5,652 | 28,070 | 51,017 | (261,984) | 18,294 |
Cash and cash equivalents at beginning of period.................................. | 229,576 | 224,231 | 261,371 | 255,719 | 227,649 | 176,632 | 438,616 | 420,322 |
Cash, and cash equivalents at end of period ........................................... $ 335,395 $ 229,576 $ 224,231 $ 261,371 $ 255,719 $ 227,649 $ 176,632 $ 438,616